Amneal Pharmaceuticals Files Q1 2025 10-Q
Ticker: AMRX · Form: 10-Q · Filed: May 7, 2025 · CIK: 1723128
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
Related Tickers: AMRX
TL;DR
**Amneal Q1 2025 10-Q filed. Financials and ops details out.**
AI Summary
Amneal Pharmaceuticals, Inc. filed its quarterly report for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial data and disclosures relevant to investors are presented in this report.
Why It Matters
This filing provides investors with the latest financial performance and operational details for Amneal Pharmaceuticals, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly filing (10-Q) providing routine financial updates, not indicating any immediate or unusual risks.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2025-05-07 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
- 2024-03-31 — Prior Year Quarter End Date (Provides a comparative point for the first quarter of the previous year.)
Key Players & Entities
- Amneal Pharmaceuticals, Inc. (company) — Filer of the 10-Q report
- 20250331 (date) — End of the reporting period
- 20250507 (date) — Filing date of the report
- 001-38485 (company) — SEC file number for Amneal Pharmaceuticals, Inc.
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed with the SEC on May 7, 2025.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001723128.
What is the Standard Industrial Classification (SIC) code for Amneal Pharmaceuticals, Inc.?
The SIC code for Amneal Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What was the previous fiscal year end date mentioned in the filing context?
The previous fiscal year end date mentioned is December 31, 2024.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Amneal Pharmaceuticals, Inc. (AMRX).